CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Frequent Patient Interaction +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02846558
NCT02846558N/ACompleted
CompareCT.gov

A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis

Johns Hopkins University·interventional·Posted Jul 27, 2016·Updated Jun 15, 2018

In Brief

A clinical study evaluating Frequent Patient Interaction, Timing Restriction, and 1 other intervention for Multiple Sclerosis. Completed, enrolled 54 participants.

Detailed Summary

This is a pragmatic, single-blinded randomized trial of improving adherence to dietary interventions in patients with MS who are receiving monthly natalizumab infusions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 27, 2016
Enrollment StartAug 1, 2016
Primary CompletionJun 1, 2017
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.9 years ago

Interventions

Frequent Patient Interactionother

Weekly informational and supportive text messages will be sent to patients, encouraging adherence to the calorie restriction diet.

Timing Restrictionbehavioral

Patients continue to follow their normal diet, but limit food intake to an 8-hour period during the day.

LoseIt! Smartphone Applicationdevice

Patients will be trained by study staff to download the LoseIt! application, and use it to log all food intake throughout the study duration. Data collected from the application will be the primary measure of adherence to dietary changes.